Bradford Amman has served as our chief financial officer since October 2018. From January 2017 to October 2018, Mr. Amman served as the chief financial officer and chief operations officer of InLight Medical, a manufacturer and distributor of medical devices cleared by the FDA for increased circulation and reduced pain. Prior to InLight, from 2010 to 2017, he served as CereScan Corp.’s chief financial officer. CereScan specializes in state-of-the-art functional brain imaging, utilizing a patented process, the latest generation of functional imaging SPECT and PET cameras, and the industry’s leading brain imaging software to assist in the diagnosis of a multitude of brain-related conditions and disorders. Mr. Amman served as chief financial officer of LifeVantage Corporation from 2006 to 2010, including during its initial public offering. Mr. Amman holds an MBA from the University of Notre Dame and a BS in accounting from the University of Denver.